SCHEMBL9611581

SCHEMBL9611581

Bc1ccc(C(=O)CN)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 2/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38
▸ GSK3B P49841 6/20 0.37
▸ PTPN1 P18031 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CES1 P23141 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL13738814 0.85 GSK3B (0.42) HDAC3HDAC6GSK3BPTPN1NPC1
SCHEMBL883159 0.80 SMN1; SMN2 (0.50) GSK3BPTPN1RAB9AKDM4EMAPT
SCHEMBL7824015 0.78 TSHR (0.60) ALOX15CES1SMN1; SMN2ALDH1A1ANPEP
SCHEMBL22919688 0.78 PARP10 (0.50) TDP1CYP3A4MAPTKMT2AALDH1A1
SCHEMBL13460757 0.78 KDM4E (0.41) HDAC3HDAC6GSK3BPTPN1NPC1
Hydrochloric Acid SCHEMBL690938 0.78 SMN1; SMN2 (0.48) GSK3BPTPN1RAB9AKDM4EMAPT
SCHEMBL6472979 0.78 NPC1 (0.60) PTPN1NPC1RAB9AKDM4ETDP1
SCHEMBL3181886 0.78 LMNA (0.47) NPC1RAB9AKDM4ETDP1MEN1
SCHEMBL12300577 0.78 GSK3B (0.38) HDAC3HDAC6GSK3BPTPN1NPC1
SCHEMBL17613140 0.76 SMN1; SMN2 (0.57) GSK3BNPC1RAB9AKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146896-A1 BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS PARION SCIENCES, INC. (US) 2023-08-03 — — WO disclosed
EP-2146984-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-05-30 — — EP disclosed
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 — — WO disclosed
WO-2011068941-A2 PROLINE DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-06-09 — — WO disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 — — WO disclosed
WO-2009102325-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 — — WO disclosed
WO-2008021927-A2 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-02-21 — — WO disclosed
Send feedback